Duration: 30 minutes
This seminar highlights the needs and versatility of ultrahigh-resolution mass spectrometers for heightened mAb characterization in Pfizer’s MSBC lab, as well as addresses the importance of different separation techniques coupled to MS. Following introduction to Pfizer’s biotherapeutic heightened characterization strategy, discussions will be focused on in-depth understanding of biotherapeutics at the subunit level and hotspot characterization at the peptide level.
We invite you to join this webinar to stay up-to-date on recent advancements in mass spectrometry.
Leah Wang, Ph.D.
For Research Use Only. Not for use in clinical diagnostic procedures.